Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  European Journal of Pharmacology

• Publication date

  1999-04-29

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/S0014-2999(99)00184-3PMID 10357247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mode of synaptic activation of pyramidal neurons in the cat primary somatosensory cortex: an intracellular HRP study

  2004cited by this paper
• An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-Amphetamine and apomorphine

  2004cited by this paper
• OCD-Like Behaviors Caused by a Neuropotentiating Transgene Targeted to Cortical and Limbic D1+ Neurons

  1999cited by this paper
• Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.

  1998cited by this paper
• Detecting subtle differences in behavior using waveform display analysis.

  1998cited by this paper
• Dopaminergic Regulation of Extracellular γ-Aminobutyric Acid Levels in the Prefrontal Cortex of the Rat

  1998cited by this paper
• Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice.

  1997cited by this paper
• Behavioural pharmacology of glutamate receptors in the basal ganglia.

  1997cited by this paper
• Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder.

  1996cited by this paper
• Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding

  1996cited by this paper
• Chapter II The basal ganglia

  1996cited by this paper
• Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare.

  1995cited by this paper
• Neurocircuitries and neurotransmitter interactions in schizophrenia

  1995cited by this paper
• D1 and D2 Receptor Gene Expression in the Rat Frontal Cortex: Cellular Localization in Different Classes of Efferent Neurons

  1995cited by this paper
• Development of tolerance and reverse tolerance to haloperidol- and SCH23390-induced cataleptic effects during withdrawal periods after long-term treatment.

  1995cited by this paper
• Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain

  1995cited by this paper
• A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine.

  1994cited by this paper
• Neuroleptics cause stimulation of dopamine D1 receptors and their desensitization after chronic treatment.

  1994cited by this paper
• Information processing within the motor cortex. II. Intracortical connections between neurons receiving somatosensory cortical input and motor output neurons of the cortex

  1994cited by this paper
• Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated.

  1993cited by this paper
• Transection of Corticostriatal Afferents Reduces Amphetamine‐ and Apomorphine‐induced Striatal Fos Expression and Turning Behaviour in Unilaterally 6‐Hydroxydopamine‐lesioned Rats

  1993cited by this paper
• Organization of cortical afferent input to orbitofrontal areas in the rhesus monkey.

  1993cited by this paper
• Localization of GABA-like immunoreactivity in the monkey amygdala.

  1993cited by this paper
• Cytoarchitecture and neural afferents of orbitofrontal cortex in the brain of the monkey

  1992cited by this paper
• Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain

  1992cited by this paper
• Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus.

  1992cited by this paper
• Childhood obsessive compulsive disorder.

  1992cited by this paper
• Treatment of Tourette syndrome with neuroleptic drugs.

  1992cited by this paper
• Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice.

  1991cited by this paper
• Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene

  1991cited by this paper
• Cerebral metabolic pattern in obsessive-compulsive disorder: altered intercorrelations between regional rates of glucose utilization.

  1991cited by this paper
• Catalepsy produced by striatal microinjections of the D1 dopamine receptor antagonist SCH 23390 in neonatal rats.

  1991cited by this paper
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

  1990cited by this paper
• Neurosurgical treatment of severe obsessive‐compulsive disorder associated with Tourette's syndrome

  1990cited by this paper
• Functional architecture of basal ganglia circuits: neural substrates of parallel processing.

  1990cited by this paper
• Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs.

  1989cited by this paper
• Effects of intrastriatal injections of selective dopamine D-1 and D-2 agonists and antagonists on jaw movements of rats.

  1989cited by this paper
• Enhancement of acoustic startle by electrical stimulation of the amygdala.

  1988cited by this paper
• Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors

  1988cited by this paper
• Organization of amygdaloid projections to the mediodorsal thalamus and prefrontal cortex: A fluorescence retrograde transport study in the rat

  1987cited by this paper
• Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain.

  1981cited by this paper
• The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.

  1980cited by this paper
• Glutamate release in vitro from corticostriatal terminals.

  1979cited by this paper
• High affinity uptake of glutamate in terminals of corticostriatal axons

  1977cited by this paper
• Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration.

  1977cited by this paper
• Lobotomy in private practice.

  1975cited by this paper
• Neuroleptic action of clozapine injected into various brain areas in rats.

  1975cited by this paper
• Lobotomy in Private Practice: Long-Term Follow-up

  1975cited by this paper
• Printed in U.S.A. Copyright © 1997 by The Endocrine Society Thyroid-Specific Expression of Cholera Toxin A1 Subunit Causes Thyroid Hyperplasia and

  year unknowncited by this paper

• Pivotal Role of Slitrk1 in Adult Striatal Cholinergic Neurons in Mice: Implication in Tourette Syndrome

  2023cites this paper
• Biochemical markers of striatal desensitization in cortical-limbic hyperglutamatergic TS- & OCD-like transgenic mice.

  2018cites this paper
• Back to the Future: Circuit-testing TS & OCD

  2017cites this paper
• The D1CT‐7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement

  2016influential citation
• 4 – Animal models for studying obsessive-compulsive and related disorders

  2016cites this paper
• "Hyperglutamatergic cortico-striato-thalamo-cortical circuit" breaker drugs alleviate tics in a transgenic circuit model of Tourette׳s syndrome.

  2015cites this paper
• Animal models of obsessive-compulsive spectrum disorders

  2013cites this paper
• The making and evaluating of animal models of obsessive-compulsive disorder

  2012cites this paper
• Current animal models of obsessive compulsive disorder: an update.

  2012cites this paper
• Serotonin and Beyond: A Neurotransmitter Perspective of OCD

  2012cites this paper
• CROSS-SPECIES MODELS OF OBSESSIVE-COMPULSIVE SPECTRUM DISORDERS

  2010cites this paper
• Cross-species models of OCD spectrum disorders.

  2009cites this paper
• Trichotillomania: neurobiology and treatment.

  2009cites this paper
• Regulation of Dopamine Signaling by D1 Receptor Membrane Trafficking

  2009cites this paper
• Animal Models of Obsessive–Compulsive Disorder: From Bench to Bedside via Endophenotypes and Biomarkers

  2008cites this paper
• Nicotine sensitization in adult male and female rats quinpirole-primed as neonates

  2008cites this paper
• Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients

  2007cites this paper
• Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors

  2006cites this paper
• Current animal models of obsessive compulsive disorder: a critical review.

  2006influential citation
• The signal attenuation rat model of obsessive–compulsive disorder: a review

  2006cites this paper
• The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence.

  2004cites this paper
• S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: III. Actions in Models of Potential Antidepressive and Anxiolytic Activity in Comparison with Ropinirole

  2004influential citation
• Selective Alleviation of Compulsive Lever-Pressing in Rats by D1, but not D2, Blockade: Possible Implications for the Involvement of D1 Receptors in Obsessive–Compulsive Disorder

  2003cites this paper
• Compulsive behavior in the 5-HT2C receptor knockout mouse.

  2003cites this paper
• Dopaminergic Neurotransmission in Tourette’s Syndrome

  2003cites this paper
• A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry

  2002cites this paper
• Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6‐hydroxydopamine

  2001cites this paper
• Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder.

  2000cites this paper
• Themed Issue: Translational Neuropharmacology – Using Appropriate Animal Models to Guide Clinical Drug Development Translational Approaches to Obsessive-compulsive Disorder: from Animal Models to Clinical Treatment Received Revised Linked Articles Validation Criteria for Animal Models Clinical Profi

  year unknowncites this paper